Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions

Lancet Microbe. 2024 Feb;5(2):e100-e101. doi: 10.1016/S2666-5247(23)00344-0. Epub 2023 Nov 23.
No abstract available

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • COVID-19* / epidemiology
  • Humans
  • Mycoplasma pneumoniae
  • Pandemics / prevention & control
  • Pneumonia, Mycoplasma* / drug therapy
  • Pneumonia, Mycoplasma* / epidemiology

Substances

  • Anti-Bacterial Agents